2020
A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.
Psutka S, Gulati R, Jewett M, Fadaak K, Finelli A, Morgan T, Pierorazio P, Allaf M, Herrin J, Lohse C, Thompson R, Boorjian S, Atwell T, Schmit G, Costello B, Legere L, Shah N, Leibovich B. A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity. Journal Of Clinical Oncology 2020, 38: 610-610. DOI: 10.1200/jco.2020.38.6_suppl.610.Peer-Reviewed Original ResearchCancer-specific mortalityRenal cortical massesCharlson Comorbidity IndexPerformance statusActive surveillancePersonalized treatment selectionCortical massTreatment selectionThermal ablationContemporary multi-institutional cohortTreatment-specific probabilitiesECOG performance statusTreatment-associated complicationsMulti-institutional cohortCause of deathClinical decision aidCause of mortalityCause mortalityComorbidity indexEligible patientsPatient characteristicsComplication ratePatient ageRadiological featuresComplication risk
2019
Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries
Jean RA, Bongiovanni T, Soulos PR, Chiu AS, Herrin J, Kim N, Xu X, Kim AW, Gross CP. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries. The Annals Of Thoracic Surgery 2019, 108: 1710-1716. PMID: 31400321, DOI: 10.1016/j.athoracsur.2019.06.048.Peer-Reviewed Original ResearchConceptsStage I non-small cell lung carcinomaNon-small cell lung carcinomaCell lung carcinomaHospital volumeLung carcinomaComplication rateMedicare beneficiariesExcess costsEnd Results-MedicareIndex hospital costsLung cancer careMean excess costLung cancer resectionHospital-level variationNumber of complicationsLung cancer treatmentEpisode of careCost of careLowest cost quintileIndex hospitalizationCancer resectionHospital factorsPerioperative careHospital variationSurgical hospitalization
2016
Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications
Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications. European Urology 2016, 71: 55-65. PMID: 26995328, DOI: 10.1016/j.eururo.2016.03.015.Peer-Reviewed Original ResearchConceptsRate of biopsyProstate-specific antigen (PSA) screeningPredictors of complicationsPostbiopsy complicationsUSPSTF recommendationsAntigen screeningProstate biopsyRelative morbidityScreening TrialUS Preventive Services Task Force (USPSTF) recommendationOvarian Cancer Screening TrialAmerican Urological Association guidelinesMorbidity of biopsyPrior fluoroquinolone useEuropean Randomized StudyCancer Screening TrialInterrupted time series analysisProportion of menTask Force recommendationsInfectious complicationsAnticoagulant useComplication rateUnderwent biopsyRandomized studyScreening guidelines
2013
Association between physicians’ experience after training and maternal obstetrical outcomes: cohort study
Epstein AJ, Srinivas SK, Nicholson S, Herrin J, Asch DA. Association between physicians’ experience after training and maternal obstetrical outcomes: cohort study. The BMJ 2013, 346: f1596. PMID: 23538919, PMCID: PMC3610558, DOI: 10.1136/bmj.f1596.Peer-Reviewed Original ResearchConceptsMaternal complication ratesMaternal complicationsComplication rateRetrospective cohort analysisAcute care hospitalsObstetrical outcomesCesarean deliveryCohort studyCare hospitalVaginal deliveryCesarean birthCompletion of residencyCohort analysisPhysician yearsMAIN OUTCOMEThird decadePost-residency practiceComplicationsObstetriciansMore yearsSecular trendsComposite measurePercentage pointsAssociationSecond decade
2012
Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009
Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B, Lesnikoski BA, Long JB, Gross CP. Patterns of Use and Short-Term Complications of Breast Brachytherapy in the National Medicare Population From 2008–2009. Journal Of Clinical Oncology 2012, 30: 4302-4307. PMID: 23091103, PMCID: PMC3675700, DOI: 10.1200/jco.2012.43.5297.Peer-Reviewed Original ResearchConceptsWhole breast irradiationHospital referral regionsBone complicationsClinical characteristicsSkin complicationsEarly-stage breast cancerNational treatment patternsPercent of patientsShort-term complicationsBreast-conserving surgeryNational Medicare populationComplication rateTreatment patternsAge 66Breast cancerReferral regionsMedicare populationPatterns of useComplicationsMedicare beneficiariesTreatment groupsClinical practiceBreast brachytherapyBrachytherapyInstrumental variable analysisShort-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009.
Presley C, Soulos P, Herrin J, Roberts K, Yu J, Killelea B, Lesnikoski B, Long J, Gross C. Short-term complications and use of breast brachytherapy in the national Medicare population in 2008-2009. Journal Of Clinical Oncology 2012, 30: 1030-1030. DOI: 10.1200/jco.2012.30.15_suppl.1030.Peer-Reviewed Original ResearchWhole breast irradiationHospital referral regionsBone complicationsClinical characteristicsSkin complicationsReferral regionsEarly-stage breast cancerNational treatment patternsOne-year overallReceipt of chemotherapyNumber of comorbiditiesShort-term complicationsDeep tissuesNational Medicare populationAdjuvant radiationComplication rateTreatment patternsDiagnosis codesBreast cancerMedicare claimsMedicare populationComplicationsMedicare beneficiariesTreatment groupsClinical practiceProton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.
Yu J, Soulos P, Cramer L, Roberts K, Herrin J, Potosky A, Gross C. Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Journal Of Clinical Oncology 2012, 30: 4651-4651. DOI: 10.1200/jco.2012.30.15_suppl.4651.Peer-Reviewed Original ResearchProstate cancer patientsSix monthsShort-term toxicityOne-yearCancer patientsPRT patientsProstate cancerProton radiotherapyLogistic regressionTreatment-related complicationsOne-year outcomesCumulative complication rateMultivariable logistic regressionPatient-reported outcomesPatterns of careConditional logistic regressionHigher socioeconomic statusGU complicationsGU toxicityComplication rateEarly toxicityDiagnosis codesLong-term effectsRadiation therapyMedicare population
2010
Evaluating Obstetrical Residency Programs Using Patient Outcomes
Asch D, Nicholson S, Srinivas S, Herrin J, Epstein A. Evaluating Obstetrical Residency Programs Using Patient Outcomes. Obstetrical & Gynecological Survey 2010, 65: 152-153. DOI: 10.1097/01.ogx.0000369668.11531.b4.Peer-Reviewed Original ResearchMaternal complicationsObstetric outcomesCesarean deliveryPatient outcomesResidency programsNonfederal acute care hospitalsMaternal complication ratesHospital discharge dataAcute care hospitalsDelivery modeGynecology residency programsDifferent obstetriciansNonclinical measuresComplication rateCare hospitalObstetric patientsVaginal deliveryClinical outcomesRetrospective studyComplication measuresAdjusted ratesComplicationsPossible associationPatient choiceTraining program
2009
Evaluating Obstetrical Residency Programs Using Patient Outcomes
Asch DA, Nicholson S, Srinivas S, Herrin J, Epstein AJ. Evaluating Obstetrical Residency Programs Using Patient Outcomes. JAMA 2009, 302: 1277-1283. PMID: 19773562, DOI: 10.1001/jama.2009.1356.Peer-Reviewed Original ResearchMeSH KeywordsAdultCesarean SectionClinical CompetenceComorbidityConfounding Factors, EpidemiologicDelivery, ObstetricExtraction, ObstetricalFemaleFloridaGynecologyHumansInternship and ResidencyMaleMothersNew YorkObstetricsOdds RatioOutcome Assessment, Health CarePhysicians, WomenPostpartum HemorrhagePuerperal InfectionQuality of Health CareResearch DesignRetrospective StudiesSurgical Wound InfectionConceptsMaternal complication ratesComplication rateCesarean deliveryPatient outcomesResidency programsGynecology training programsAdjusted complication rateQuality of careExamination scoresGynecology residency programsMaternal complicationsNonclinical measuresHospital dischargeVaginal deliveryCesarean birthRetrospective analysisComplicationsUS residency programsPatientsObstetriciansBottom quintileTop quintileHemorrhageObstetricsOne-third